Pharmatics is a trailblazing startup leveraging evidence-based AI to revolutionize the realms of digital health and precision medicine. The company's compelling slogan, "Evidence-Based AI for Digital Health and Precision Medicine," underscores its core mission. Pharmatics specializes in evidence-based medical AI, amalgamating insights from data with the latest medical evidence automatically synthesized from scientific biomedical articles, encompassing primary research, clinical trials, and systematic reviews. The company's flagship offering, MedAI service, significantly reduces time to market and costs, while enhancing the trustworthiness of AI developments and deployments in the healthcare sector. It achieves this by identifying and integrating pertinent results developed globally and converting them into predictive models accessible via an API. This groundbreaking approach effectively mitigates bias, elevates performance, comprehensibility, and trustworthiness of medical AI built from extensive and limited datasets. Having been established in 2011, Pharmatics operates at the confluence of AI, Big Data, Data Analytics, Health Care, and Machine Learning, positioning itself at the forefront of cutting-edge innovation. Although specifics concerning its headquarters, last investment, last investment investors are currently unavailable, Pharmatics showcases tremendous potential to disrupt and elevate the landscape of healthcare technology.
There is no investment information
No recent news or press coverage available for Pharmatics.